Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Therapeutic Advances in Chronic Disease
|
November 10, 2025
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
David Rosmarin, Thierry Passeron, Amit G Pandya, et al.
Dermatology and Therapy
|
March 2, 2026
The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study
Andrew Alexis, Amy McMichael, Neelam Vashi, et al.
International Journal of Women'S Dermatology
|
October 8, 2021
Embracing diversity in dermatology: Creation of a culture of equity and inclusion in dermatology
Seemal R Desai, Rayva Khanna, Donald Glass, et al.
JAMA Dermatology
|
December 11, 2024
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement
Andrew Alexis, Amy McMichael, Neelam Vashi, et al.
JAMA Dermatology
|
March 13, 2024
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients
Yael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, et al.
Pigment Cell & Melanoma Research
|
January 28, 2020
Proceeding Report of the Second Vitiligo International Symposium-November 9-10, 2018, Detroit, Michigan, USA
Alexis B Lyons, Deepti Ghia, Marwa Abdallah, et al.
Journal of the American Academy of Dermatology
|
February 10, 2024
Treatment for central centrifugal cicatricial alopecia-Delphi consensus recommendations
Tiaranesha Jackson, Yacine Sow, Jewell Dinkins, et al.
JAMA Dermatology
|
June 25, 2025
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial
Andrew Alexis, Amy McMichael, Jennifer Soung, et al.
JAMA Dermatology
|
June 25, 2025
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial
Amy McMichael, Mona Shahriari, Linda Stein Gold, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 25, 2023
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm
Nanja van Geel, Reinhart Speeckaert, Alain Taïeb, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Therapeutic Advances in Chronic Disease
|
November 10, 2025
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
David Rosmarin, Thierry Passeron, Amit G Pandya, et al.
Dermatology and Therapy
|
March 2, 2026
The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study
Andrew Alexis, Amy McMichael, Neelam Vashi, et al.
International Journal of Women'S Dermatology
|
October 8, 2021
Embracing diversity in dermatology: Creation of a culture of equity and inclusion in dermatology
Seemal R Desai, Rayva Khanna, Donald Glass, et al.
JAMA Dermatology
|
December 11, 2024
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement
Andrew Alexis, Amy McMichael, Neelam Vashi, et al.
JAMA Dermatology
|
March 13, 2024
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients
Yael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, et al.
Pigment Cell & Melanoma Research
|
January 28, 2020
Proceeding Report of the Second Vitiligo International Symposium-November 9-10, 2018, Detroit, Michigan, USA
Alexis B Lyons, Deepti Ghia, Marwa Abdallah, et al.
Journal of the American Academy of Dermatology
|
February 10, 2024
Treatment for central centrifugal cicatricial alopecia-Delphi consensus recommendations
Tiaranesha Jackson, Yacine Sow, Jewell Dinkins, et al.
JAMA Dermatology
|
June 25, 2025
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial
Andrew Alexis, Amy McMichael, Jennifer Soung, et al.
JAMA Dermatology
|
June 25, 2025
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial
Amy McMichael, Mona Shahriari, Linda Stein Gold, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 25, 2023
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm
Nanja van Geel, Reinhart Speeckaert, Alain Taïeb, et al.
Page
of 6